Search

Your search keyword '"Oudart JB"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Oudart JB" Remove constraint Author: "Oudart JB"
46 results on '"Oudart JB"'

Search Results

1. IMMUNOTHERAPY IN NSCLC : FROM TARGETED MOLECULES TO RESISTANCE PATTERNS

2. Type XIX collagen : A new partner in the interactions between tumor cells and their microenvironment

3. STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trial.

4. Serum S100B Level in the Management of Pediatric Minor Head Trauma: A Randomized Clinical Trial.

5. Prospective 25-year surveillance of prion diseases in France, 1992 to 2016: a slow waning of epidemics and an increase in observed sporadic forms.

6. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview.

7. Mutational Characteristics of Primary Mucosal Melanoma: A Systematic Review.

8. F4, a collagen XIX-derived peptide, inhibits tumor angiogenesis through αvβ3 and α5β1 integrin interaction.

9. Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC.

11. PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project.

12. A Mysteriously Low Creatinine Concentration.

13. [Clinical and biological features of haptoglobin phenotypes].

14. Extracellular Vesicle-Dependent Cross-Talk in Cancer-Focus on Pancreatic Cancer.

15. Angiogenesis Inhibition by a Short 13 Amino Acid Peptide Sequence of Tetrastatin, the α4(IV) NC1 Domain of Collagen IV.

16. Immunotherapy in non-small-cell lung cancer: from targeted molecules to resistance patterns.

17. Incremental Value of CSF Biomarkers in Clinically Diagnosed AD and Non-AD Dementia.

19. Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression.

20. Molecular markers and prediction of response to immunotherapy in non-small cell lung cancer, an update.

21. Conformation-dependent binding of a Tetrastatin peptide to α v β 3 integrin decreases melanoma progression through FAK/PI 3 K/Akt pathway inhibition.

22. Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?

23. Unexpected M-protein in an Anticoagulated Patient.

24. Tau protein as a possible marker of cerebrospinal fluid leakage in cerebrospinal fluid rhinorrhoea: A pilot study.

25. Confusing Hyperkalemia.

26. Type XIX collagen: A new partner in the interactions between tumor cells and their microenvironment.

27. Unexpected Creatinine Values.

28. Evaluation of Lumipulse® G1200 for the measurement of six tumor markers: Comparison with AIA® 2000.

29. Homocitrulline as marker of protein carbamylation in hemodialyzed patients.

30. Unexpected Case of Bright Pink-Colored Plasma.

31. Analytical interference in the therapeutic drug monitoring of methotrexate.

32. Milky Pleural Fluid.

33. The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction.

34. A competitive enzyme-linked immunosorbent assay for quantification of tetrastatin in body fluids and tumor extracts.

35. [An acute monoclonal gammopathy?].

36. Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX.

37. Endostatin level in cerebrospinal fluid of patients with Alzheimer's disease.

39. Matrikines from basement membrane collagens: a new anti-cancer strategy.

40. [Urinary investigations in the diagnosis and monitoring of monoclonal gammopathies in daily practice].

41. Interference of M-paraprotein in automated urea assays.

42. Analytical methods for measuring collagen XIX in human cell cultures, tissue extracts, and biological fluids.

43. Encapsulation of contrast imaging agents by polypropyleneimine-based dendrimers.

44. [Recommendations for the management of monoclonal gammopathies in biochemistry].

45. Pleural effusion in a patient with multiple myeloma.

46. [Hyperamylasemia after cardiac surgery: which significance?].

Catalog

Books, media, physical & digital resources